Mohammad Imran
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in ⓘ
-
- RNA Interference and Gene Delivery 4
- Bacterial biofilms and quorum sensing 3
-
- Advancements in Transdermal Drug Delivery 10
- Co-authors
- Yousuf Mohammed (20 shared papers)Anas Ahmad (2 shared papers)Nazeer Hasan (13 shared papers)Javed Ali (5 shared papers)Sanjula Baboota (5 shared papers)Haseeb Ahsan (1 shared paper)Sadaf Saleem (2 shared papers)Prashant Kesharwani (10 shared papers)
- Journals
- Pharmaceutics (5 papers)International Journal of Pharmaceutics (4 papers)Environmental Research (3 papers)Drug Delivery and Translational Research (2 papers)Nanomedicine (2 papers)
- Partner nations
- IndiaAustraliaSouth Korea
In The Last Decade
Mohammad Imran
49 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Pharmaceutical Science 350
- Biomaterials 255
- Dermatology 164
- Molecular Medicine 67
- Immunology 135
Countries citing papers authored by Mohammad Imran
This map shows the geographic impact of Mohammad Imran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Imran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Imran more than expected).
Fields of papers citing papers by Mohammad Imran
This network shows the impact of papers produced by Mohammad Imran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Imran. The network helps show where Mohammad Imran may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Imran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 168 | |
| 2 | Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases Hit paper breakdown → | 2023 | 127 |
| 3 | Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches Hit paper breakdown → | 2023 | 123 |
| 4 | 2020 | 100 | |
| 5 | 2021 | 75 | |
| 6 | 2022 | 58 | |
| 7 | 2022 | 58 | |
| 8 | 2022 | 51 | |
| 9 | 2023 | 47 | |
| 10 | 2022 | 46 | |
| 11 | 2023 | 45 | |
| 12 | 2022 | 41 | |
| 13 | 2023 | 39 | |
| 14 | 2019 | 29 | |
| 15 | 2022 | 26 | |
| 16 | 2023 | 25 | |
| 17 | 2022 | 25 | |
| 18 | 2023 | 25 | |
| 19 | 2021 | 24 | |
| 20 | 2023 | 24 |
About Mohammad Imran
Mohammad Imran is a scholar working on Molecular Biology, Pharmaceutical Science, Biomaterials, Dermatology and Molecular Medicine, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (10 papers), Nanoparticle-Based Drug Delivery (6 papers), RNA Interference and Gene Delivery (4 papers), Dermatology and Skin Diseases (3 papers), Skin Protection and Aging (3 papers), Bacterial biofilms and quorum sensing (3 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Curcumin's Biomedical Applications (3 papers). The work is most often cited by research in Pharmaceutical Science (350 citations), Biomaterials (255 citations), Dermatology (164 citations), Molecular Medicine (67 citations) and Immunology (135 citations). Mohammad Imran has collaborated with scholars based in India, Australia and South Korea. Frequent co-authors include Yousuf Mohammed, Anas Ahmad, Nazeer Hasan, Javed Ali, Sanjula Baboota, Haseeb Ahsan, Sadaf Saleem, Prashant Kesharwani, Farhan Jalees Ahmad and Keshav Raj Paudel. Their work appears in journals such as Pharmaceutics, International Journal of Pharmaceutics, Environmental Research, Drug Delivery and Translational Research and Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.